ZA959255B - Antibodies against allogenic and xenogenic proteins their use in diagnosis and therapy and methods for the determination thereof - Google Patents

Antibodies against allogenic and xenogenic proteins their use in diagnosis and therapy and methods for the determination thereof

Info

Publication number
ZA959255B
ZA959255B ZA959255A ZA959255A ZA959255B ZA 959255 B ZA959255 B ZA 959255B ZA 959255 A ZA959255 A ZA 959255A ZA 959255 A ZA959255 A ZA 959255A ZA 959255 B ZA959255 B ZA 959255B
Authority
ZA
South Africa
Prior art keywords
diagnosis
therapy
determination
methods
antibodies against
Prior art date
Application number
ZA959255A
Other languages
English (en)
Inventor
Alberto Bartorelli
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of ZA959255B publication Critical patent/ZA959255B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/734—Complement-dependent cytotoxicity [CDC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA959255A 1994-11-04 1995-11-02 Antibodies against allogenic and xenogenic proteins their use in diagnosis and therapy and methods for the determination thereof ZA959255B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT94MI002238A IT1276860B1 (it) 1994-11-04 1994-11-04 Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione

Publications (1)

Publication Number Publication Date
ZA959255B true ZA959255B (en) 1996-05-29

Family

ID=11369803

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA959255A ZA959255B (en) 1994-11-04 1995-11-02 Antibodies against allogenic and xenogenic proteins their use in diagnosis and therapy and methods for the determination thereof

Country Status (26)

Country Link
EP (1) EP0789716B1 (es)
JP (1) JPH10508591A (es)
KR (1) KR100426029B1 (es)
CN (1) CN1046737C (es)
AR (1) AR002243A1 (es)
AT (1) ATE192166T1 (es)
AU (1) AU690756B2 (es)
BR (1) BR9509556A (es)
CA (1) CA2204380A1 (es)
CZ (1) CZ288322B6 (es)
DE (1) DE69516534T2 (es)
DK (1) DK0789716T3 (es)
ES (1) ES2147617T3 (es)
FI (1) FI971879A (es)
GR (1) GR3033956T3 (es)
HU (1) HUT76880A (es)
IL (1) IL115862A (es)
IT (1) IT1276860B1 (es)
NO (1) NO972046L (es)
NZ (1) NZ295171A (es)
PL (1) PL181115B1 (es)
PT (1) PT789716E (es)
RU (1) RU2160445C2 (es)
TR (1) TR199501353A2 (es)
WO (1) WO1996014340A1 (es)
ZA (1) ZA959255B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283634B1 (it) * 1996-05-10 1998-04-23 Zetesis Spa Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali
US20010014471A1 (en) * 1999-04-15 2001-08-16 Vytautas Naktinis Recombinant protein and its use in therapy and diagnostics
IT201600127428A1 (it) * 2016-12-16 2018-06-16 Cusani Alberto Bartorelli Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne
IT201900022203A1 (it) * 2019-11-26 2021-05-26 Cusani Alberto Bartorelli Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1244879B (it) * 1990-12-11 1994-09-12 Alberto Bartorelli Estratti da tessuti animali, utili in terapia e in diagnostica.

Also Published As

Publication number Publication date
EP0789716B1 (en) 2000-04-26
AU690756B2 (en) 1998-04-30
MX9703191A (es) 1997-07-31
PL319878A1 (en) 1997-09-01
KR970707161A (ko) 1997-12-01
TR199501353A2 (tr) 1996-06-21
ITMI942238A0 (it) 1994-11-04
RU2160445C2 (ru) 2000-12-10
CZ131497A3 (en) 1997-12-17
BR9509556A (pt) 1997-09-16
PL181115B1 (pl) 2001-05-31
NO972046D0 (no) 1997-05-02
NZ295171A (en) 1998-07-28
KR100426029B1 (ko) 2004-07-31
JPH10508591A (ja) 1998-08-25
FI971879A (fi) 1997-06-24
IL115862A (en) 2001-06-14
WO1996014340A1 (en) 1996-05-17
CN1166838A (zh) 1997-12-03
GR3033956T3 (en) 2000-11-30
FI971879A0 (fi) 1997-05-02
ATE192166T1 (de) 2000-05-15
AU3845395A (en) 1996-05-31
AR002243A1 (es) 1998-03-11
NO972046L (no) 1997-05-02
DK0789716T3 (da) 2000-10-09
ITMI942238A1 (it) 1996-05-04
CA2204380A1 (en) 1996-05-17
IL115862A0 (en) 1996-01-31
DE69516534D1 (de) 2000-05-31
EP0789716A1 (en) 1997-08-20
IT1276860B1 (it) 1997-11-03
ES2147617T3 (es) 2000-09-16
HUT76880A (en) 1997-12-29
CN1046737C (zh) 1999-11-24
CZ288322B6 (en) 2001-05-16
PT789716E (pt) 2000-09-29
DE69516534T2 (de) 2000-11-30

Similar Documents

Publication Publication Date Title
EE9700030A (et) Kehakaalu modulaatorid, neile vastavad nukleiinhapped ja valgud ning nende kasutamine diagnostikas ja teraapias
EP0573060A3 (en) Device and method for examining exhaled air for clinical purposes.
PL337667A1 (en) Superficially acting antigens and proteins useful in diagnostic compositions and in preventing lymean borreliosis
EP0805161A4 (en) PROTEIN BINDING (1-3) -BETA-D-GLUCANE, PROTEIN RECOGNIZING ANTIBODIES AND USE OF PROTEIN AND ANTIBODY
DE69714676D1 (de) Blutkultur-Apparat mit Selbstentlade- und Sortiervorrichtung
EP0831793A4 (en) PROTEIN PARTICLES FOR THERAPEUTIC AND DIAGNOSTIC USE
EP0965840A4 (en) METHOD FOR ANALYZING ANNEXIN V IN URINE AND THEIR USE
GB9617616D0 (en) Assaying protein fragments in body fluids
GB9419553D0 (en) Polypeptides and their use in the treatment of auto-immune disease
IL122094A0 (en) In situ - generated solid radiation source based on tungsten188/rhenium188 and the use thereof
ZA959255B (en) Antibodies against allogenic and xenogenic proteins their use in diagnosis and therapy and methods for the determination thereof
EP0439208A3 (en) Method and kits for detecting human leukocyte antigen dna
ZA953027B (en) Composition for use in raising an immune response
EP0461473A3 (en) Method and means for eliminating clouding in biological fluids
GB9423372D0 (en) Proteins and their uses
IL96369A0 (en) Decapeptide,monoclonal antibodies directed thereto and their use in diagnosis
AU3628697A (en) Lipid-binding proteins and their therapeutic and diagnostic use
IL109540A0 (en) Synthetic peptides and their use in tumor diagnosis and therapy
AU3728595A (en) Antibodies against an extracellular matrix complex and their use in the detection of cancer
WO1994006345A3 (en) Immunosorbent for use in the diagnosis of neuro-psychological disorders, and use thereof
IL113347A (en) Brain endothelial cell protein and methods for its use
GB9621093D0 (en) Antigen for use in cancer therapy and diagnosis
GB9614416D0 (en) Antigen for use in cancer therapy and diagnosis
SE9503044D0 (sv) Antibodies for use in cancer therapy and diagnosis
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis